Sanofi and GSK Say COVID-19 Vaccine Did Well in Trial, Will Seek US Clearance
A COVID-19 vaccine created by Sanofi and GlaxoSmithKline (GSK) performed well in a clinical trial, the companies said ...
Stay updated with breaking news from Thomas Triomphe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A COVID-19 vaccine created by Sanofi and GlaxoSmithKline (GSK) performed well in a clinical trial, the companies said ...
Sanofi and GSK said Wednesday that they plan to submit their COVID-19 vaccine for authorization following "strong" results in a Phase 3 trial.
Drugmakers Sanofi and GlaxoSmithKline announced Wednesday they are planning to ask regulators to authorize their new COVID-19 vaccine candidate.
Thiago Prudencio/SOPA Images/LightRocket via Getty Images (WASHINGTON) — Drugmakers Sanofi and GlaxoSmithKline announced Wednesday they are planning to ask
Pharmaceutical giants Sanofi and GSK have submitted a joint-application to the FDA for authorization for a two-dose COVID-19 vaccine and booster shot.